Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Expert Rev Anti Infect Ther ; 12(5): 549-54, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24689705

RESUMO

In the era of multidrug resistance, it is critical to utilize antibiotics in an appropriate manner and to identify new treatments or revisit the use of 'forgotten' drugs. Because urinary tract infections (UTIs) are common, particularly in an increasing elderly population, the 'forgotten' drug, methenamine, may become important as a preventive therapy for recurrent UTIs. Methenamine, a urinary antibacterial agent, can be used as methenamine hippurate or methenamine mandelate preparations and is United States Food and Drug Administration-approved. This article discusses the place of preventive therapy for recurrent UTIs, chemistry, mechanism of action, pharmacology, clinical uses, dosage, adverse reactions and safety, and drug interactions of methenamine. Because of its unique antiseptic property, the authors suggest that methenamine should be considered when more commonly used antibiotics fail to suppress recurrent UTIs.


Assuntos
Anti-Infecciosos Urinários/uso terapêutico , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Hipuratos/uso terapêutico , Ácidos Mandélicos/uso terapêutico , Metenamina/análogos & derivados , Infecções Urinárias/tratamento farmacológico , Anti-Infecciosos Urinários/efeitos adversos , Anti-Infecciosos Urinários/farmacocinética , Esquema de Medicação , Cálculos da Dosagem de Medicamento , Farmacorresistência Bacteriana Múltipla , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/fisiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Bactérias Gram-Positivas/efeitos dos fármacos , Bactérias Gram-Positivas/fisiologia , Infecções por Bactérias Gram-Positivas/microbiologia , Hipuratos/efeitos adversos , Hipuratos/farmacocinética , Humanos , Ácidos Mandélicos/efeitos adversos , Ácidos Mandélicos/farmacocinética , Metenamina/efeitos adversos , Metenamina/farmacocinética , Metenamina/uso terapêutico , Recidiva , Infecções Urinárias/microbiologia
2.
Anticancer Res ; 22(6B): 3765-76, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12552990

RESUMO

Dimethylsilane tetramines are structural analogues of spermine with a (CH3)2 Si-group incorporated into the central carbon chain. They have potential as anticancer drugs. Their cytotoxic effect was considered to rely mainly on their polyamine antagonist property. In order to obtain new ideas about cellular mechanisms, which are potential targets of the dimethylsilane polyamines, the effects of these compounds on some basic cell functions, such as protein and DNA synthesis, and calmodulin antagonism were studied. In addition, their mode of accumulation in cells was investigated. It became evident that the intracellular accumulation of dimethylsilane polyamines is almost exclusively achieved via the polyamine transport system. However, the exchange of a part of the intracellular natural polyamines against dimethylsilane polyamines has only a small effect on polyamine uptake. Binding to the endoplasmic reticulum and inhibition of protein synthesis are presumably important for the cytotoxic action of bis(11-amino-4,8-diazaundecyl)dimethylsilane, a hexamine, but seem of no importance for the tetramines. Calmodulin antagonism, however, is likely to contribute to their cytotoxic effect.


Assuntos
Antineoplásicos/farmacologia , Antineoplásicos/farmacocinética , Calmodulina/análogos & derivados , Poliaminas/farmacologia , Poliaminas/farmacocinética , Silanos/farmacologia , Silanos/farmacocinética , Animais , Células CHO/efeitos dos fármacos , Células CHO/metabolismo , Calmodulina/metabolismo , Agregação Celular/efeitos dos fármacos , Ciclo Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Cricetinae , DNA de Neoplasias/metabolismo , Ensaios de Seleção de Medicamentos Antitumorais , Leucina/antagonistas & inibidores , Leucina/metabolismo , Leucemia L1210/tratamento farmacológico , Leucemia L1210/metabolismo , Metenamina/farmacocinética , Metenamina/farmacologia , Camundongos , Microssomos Hepáticos/efeitos dos fármacos , Oxirredutases atuantes sobre Doadores de Grupo CH-NH/antagonistas & inibidores , Oxirredutases atuantes sobre Doadores de Grupo CH-NH/metabolismo , Ratos , Espermidina/antagonistas & inibidores , Espermidina/farmacocinética , Timidina/antagonistas & inibidores , Timidina/metabolismo
3.
J Endod ; 21(3): 122-7, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7561653

RESUMO

Four root canal sealers (AH-26, Roth 811, CRCS, and Sealapex) were tested for tissue biocompatibility in rat connective tissue. Each sealer was placed in Teflon tubes and implanted subcutaneously in Wistar-Furth rats. The implants were removed after 7, 14, and 21 days, fixed, and histologically prepared for microscopical evaluation. Brain, liver, kidneys, and uterus were removed from the animals killed at the first experimental period (7 days) and analyzed for zinc and calcium concentration by flame atomic absorption spectrophotometry. In total, 100 specimens were examined. At the seventh day, the most irritant material was seen to be AH-26, but this inflammatory reaction decreased with time. Roth 811 and Sealapex caused moderate-to-severe inflammatory reaction, whereas CRCS caused mild to moderate. CRCS and Roth 811 induced redistribution of zinc, whereas AH-26 induced changes in calcium content in some organs.


Assuntos
Tecido Conjuntivo/efeitos dos fármacos , Resinas Epóxi , Materiais Restauradores do Canal Radicular/efeitos adversos , Salicilatos , Animais , Materiais Biocompatíveis/efeitos adversos , Materiais Biocompatíveis/farmacocinética , Bismuto/efeitos adversos , Bismuto/farmacocinética , Química Encefálica , Cálcio/análise , Hidróxido de Cálcio/efeitos adversos , Hidróxido de Cálcio/farmacocinética , Tecido Conjuntivo/metabolismo , Combinação de Medicamentos , Feminino , Reação a Corpo Estranho/etiologia , Rim/química , Fígado/química , Metenamina/efeitos adversos , Metenamina/farmacocinética , Ratos , Ratos Wistar , Materiais Restauradores do Canal Radicular/farmacocinética , Prata/efeitos adversos , Prata/farmacocinética , Distribuição Tecidual , Titânio/efeitos adversos , Titânio/farmacocinética , Útero/química , Zinco/análise , Óxido de Zinco/efeitos adversos , Óxido de Zinco/farmacocinética , Cimento de Óxido de Zinco e Eugenol/efeitos adversos , Cimento de Óxido de Zinco e Eugenol/farmacocinética
6.
J Pharm Sci ; 70(9): 1017-24, 1981 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6101145

RESUMO

Dissolution profiles were determined for nine methenamine, 14 nitrofurantoin, and six chlorothiazide dosage forms using a dissolution simulator. Various in vivo-in vitro correlations were examined. The best correlation for methenamine was between the maximum urinary excretion rate and the time for 15% dissolution. A good correlation for the 50-mg nitrofurantoin tablets was also found between cumulative percent of drug excreted in 12 hr and the percent dissolved in 1 hr. There were no significant correlations for the 100-mg nitrofurantoin dosage forms. Good correlations were also observed for the 250- and 500-mg chlorothiazide tablets between the percent of drug dissolved in 1 min or the time for 15% dissolution and the maximum excretion rate.


Assuntos
Clorotiazida/farmacocinética , Metenamina/farmacocinética , Nitrofurantoína/farmacocinética , Absorção , Clorotiazida/química , Metenamina/química , Nitrofurantoína/química , Solubilidade , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...